Transce3nd’s GE HealthCare GEHC Stock Holding History

Transce3nd’s Portfolio GEHC Stock Details GEHC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-24	Closed	-$1.78K	–	538
2025 Q2	$1.78K	Buy	24 +4	+20%	+$278	﹤0.01%	901
2025 Q1	$1.61K	Sell	20 -37	-65%	-$3.18K	﹤0.01%	890
2024 Q4	$4.46K	Buy	+57	New	+$4.84K	﹤0.01%	959

Other funds holding GEHC

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Harris Associates Chicago, Illinois $75.4B AUM 14.46% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Transce3nd's GEHC Position: Q3 2025 in Review

Transce3nd sold out of GE HealthCare (GEHC) in Q3 2025, closing a stake of 24 shares — an estimated $1.78K sold.

Transce3nd first reported a position in GEHC in Q4 2024 and held it in 3 quarters. The position peaked at $4.46K in Q4 2024. 1,279 funds tracked by Wall St. Rank hold GEHC as of Q3 2025.

Transce3nd reported no remaining GE HealthCare position as of Q3 2025 after selling out during the quarter.
Transce3nd sold 24 GE HealthCare shares in Q3 2025, an estimated $1.78K.
Transce3nd first reported a position in GE HealthCare in Q4 2024 and held it in 3 quarters.
Transce3nd's GE HealthCare position peaked at $4.46K in Q4 2024.
1,279 funds tracked by Wall St. Rank held GE HealthCare as of Q3 2025.

Based on Transce3nd's 13F filing for Q3 2025, filed 12 Nov 2025.